Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease

Enrolling by invitation

Conditions studied: NAFLD

In brief

This study aims to enroll a robust cohort of NAFLD patients who undergo Intragastric Balloon placement through a multidisciplinary program approach to evaluate clinical and patient-reported outcomes for at least one-year post-placement.

Key facts

Study ID

NCT07493967

Run by

Methodist Health System

People needed

200

Starts

2024-02-23

Expected to finish

2027-02-01

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Obese (defined as a BMI >30 kg/m2 )
• Men and women scheduled to undergo immunoglobulin B placement at Methodist Dallas Medical Center(MDMC)
• 18 years or older in age
• Able to read and understand the study information
• Personally signed and dated informed consent form indicating that the subject has been informed of all pertinent aspects of the study
• Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures

You may not qualify if…

• Not meeting inclusion criteria
• Pregnant women

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.